|Group:||Group IV ((+)ssRNA)|
චිකුන්ගුන්යා යනු වෛරස් ආසාදනයකින් ඇතිවන රෝගයකි.
viral fever caused by an alphavirus that is spread by mosquito bites from the ඊඩිස් ඊඡිප්ටයි (Aedes aegypti) මදුරුවන්, though recent research by the Pasteur Institute in Paris claims the virus has suffered a mutation that enables it to be transmitted by Aedes albopictus (Tiger mosquito). This was the cause of the actual plague in the Indian Ocean and a threat to the Mediterranean coast at present.
The name is derived from the Makonde word meaning "that which bends up" in reference to the stooped posture developed as a result of the arthritic symptoms of the disease. The disease was first described by Marion Robinson and W.H.R. Lumsden in 1955, following an outbreak on the Makonde Plateau, along the border between Tanganyika and Mozambique, in 1952. Chikungunya is closely related to O'nyong'nyong virus.
Chikungunya is generally not fatal. However, in 2005-2006, 200 deaths have been associated with chikungunya on Réunion island and a widespread outbreak in India (especially in Tamil Nadu, Karnataka, Kerala, and Andhra Pradesh). Andhra Pradesh saw a huge outbreak which spread to neighbouring states. As of September 2006, after the flood and heavy rains in Rajasthan in August 2006, India, thousands of cases have been detected in Rajsamand, Bhilwara, Udaipur, and Chittorgarh districts and also in adjoining regions of Gujarat and Madhya Pradesh. As of October 12, 2006 in the southern indian state of Kerala, 125 deaths are attributed to Chikungunya and majority of the casualties were reported in the district of Alapuzha [mainly in Cherthala Taluk]. This latest outbreak in Alappuzha is supposed to have transferred from Parassala, the southrenmost point of Kerala state where a recent outbreak were reported before the episodes of Alappuzha started. Kerala government has termed this as an epidemic outbreak, whereas the TamilNadu government has refused that the deaths caused in the state wasnot due to chikungunya.
රෝග ලක්ෂණ[සංස්කරණය කරන්න]
උණ which can reach 39 °C, (102.2 °F)
සන්ධි වේදනාව (Arthralgia) or arthritis affecting multiple joints which can be debilitating.
The symptoms could also include හිසරදය (headache), conjunctival infection, and slight photophobia. In the present epidemic in the states of Andhra Pradesh and Tamil Nadu, India, high fever and crippling joint pain are the prevalent complaint. The fever typically lasts for two days and abruptly comes down. However, other symptoms, namely joint pain, intense headache, insomnia and an extreme degree of prostration last for a variable period, usually for about 5 to 7 days.
Dermatological manifestations observed in a recent outbreak of Chikungunya fever in Southern India (Dr. Arun Inamadar,Dr. Aparna Palit, Dr.V.V. Sampagavi, Dr. Raghunath S, Dr. N.S. Deshmukh), Western India (Surat) (Western India reported by Dr. Buddhadev) and Eastern India (Puri) (Dr. Milon Mitra et al) includes the following:
- Maculopapular rash
- Nasal blotchy erythema
- Freckle-like pigmentation over centro-facial area
- Flagellate pigmentation on face and extremities
- Lichenoid eruption and hyperpigmentation in photodistributed areas
- Multiple aphthous-like ulcers over scrotum, crural areas and axilla.
- Lympoedema in acral distribution (bilateral/unilateral)
- Multiple ecchymotic spots (Children)
- Vesiculobullous lesions (infants)
- Subungual hemorrhage
- Photo Urticaria
- Acral Urticaria
පාද ඉදිමීම is observed in many patients, the cause of which remains obscure as it not related to any cardiovascular, renal or hepatic abnormalities.
ඇතිවන රෝග ලක්ෂණ අනුව ප්රතිකාර ලබාදේ. Vaccine trials were carried out in 2000, but funding for the project was discontinued and there is no vaccine currently available. A serological test for Chikungunya is available from the University of Malaya in Kuala Lumpur, Malaysia.
Chloroquine is gaining ground as a possible treatment for the symptoms associated with Chikungunya and as an antiviral agent to combat the Chikungunya virus. According to the University of Malaya, "In unresolved arthritis refractory to aspirin and nonsteroidal anti-inflammatory drugs, chloroquine phosphate (250 mg/day) has given promising results."  Research by Italian scientist, Andrea Savarino, and his colleagues in addition a French government press release in March 2006  have added more credence to the claim that chloroquine may be effective in treating Chikungunya. The CDC fat sheet on Chikungunya advises against using Aspirin. Ibuprofen, Naproxen and other non-steroidal antiinflammatory drugs are recommended for arthritic pain and fever.
Infected persons should limit further exposure to mosquito bites, stay indoors and under a mosquito net. Further, "supportive care with rest is indicated during the acute joint symptoms. Movement and mild exercise tend to improve stiffness and morning arthralgia, but heavy exercise may exacerbate rheumatic symptoms." 
තවමත් එන්නතක් නිපදවා නැත. The most effective means of prevention are those that protect against any contact with the disease-carrying mosquitos. These include using insect repellent containing DEET or permethrin, wearing long sleeves and pants, and securing screens on windows and doors. It's also important to empty stagnant water where mosquitoes breed. .
වචනයේ සමිභවය[සංස්කරණය කරන්න]
According to Lumsden's initial 1955 report about the epidemiology of the disease, the term chikungunya is derived from the Makonde root verb kungunyala, meaning to dry up or become contorted. In concurrent research, Robinson glossed the Makonde term more specifically as "that which bends up." Subsequent authors apparently overlooked the references to the Makonde language and assumed that the term derived from Swahili, the lingua franca of the region. The erroneous attribution of the term as a Swahili word has been repeated in numerous print sources; Google lists over 15,000 results in a search for "chikungunya swahili". Many other spellings and forms of the term are in common use including "Chicken guinea" and Chickengunya.
අදාල වෙනත් මාතෘකා[සංස්කරණය කරන්න]
- Robinson Marion (1955). "An Epidemic of Virus Disease in Southern Province, Tanganyika Territory, in 1952-53; I. Clinical Features". Trans Royal Society Trop Med Hyg 49 (1): 28-32.
- Lumsden WHR (1955). "An Epidemic of Virus Disease in Southern Province, Tanganyika Territory, in 1952-53; II. General Description and Epidemiology". Trans Royal Society Trop Med Hyg 49 (1): 33-57.
- Vanlandingham DL, Hong C, Klingler K, Tsetsarkin K, McElroy KL, Powers AM, Lehane MJ, Higgs S (2005). "Differential infectivities of o'nyong-nyong and chikungunya virus isolates in Anopheles gambiae and Aedes aegypti mosquitoes". Am J Trop Med Hyg 72 (5): 616-21. සැකිල්ල:PMID.
General information[සංස්කරණය කරන්න]
- CDC factsheet on Chikungunya
- WHO site on disease outbreak news
- Chikungunya Research and Chikun guniya - latest publications.
- Chikungunya is not Swahili (Internet Living Swahili Dictionary)
- Chikungunya and Pregnancy
- Chikungunya and how to handle it (Mauritius)
- European Center for Disease Prevention and Control: Chikungunya Info for Travellers
- Chikungunya Infection in India and Vector Control
- Genome Microevolution of Chikungunya Viruses Causing the Indian Ocean Outbreak, NIH, July 2006.
- Chikungunya Virus Infection
- Homeopathic and other treatment for chikungunya